A proof of concept for structure-based vaccine design targeting RSV in humans

Science
Michelle C CrankVRC 317 Study Team

Abstract

Technologies that define the atomic-level structure of neutralization-sensitive epitopes on viral surface proteins are transforming vaccinology and guiding new vaccine development approaches. Previously, iterative rounds of protein engineering were performed to preserve the prefusion conformation of the respiratory syncytial virus (RSV) fusion (F) glycoprotein, resulting in a stabilized subunit vaccine candidate (DS-Cav1), which showed promising results in mice and macaques. Here, phase I human immunogenicity data reveal a more than 10-fold boost in neutralizing activity in serum from antibodies targeting prefusion-specific surfaces of RSV F. These findings represent a clinical proof of concept for structure-based vaccine design, suggest that development of a successful RSV vaccine will be feasible, and portend an era of precision vaccinology.

References

Feb 18, 1998·The Journal of Infectious Diseases·A R Falsey, E E Walsh
Jul 11, 1998·Journal of Virology·J A LópezJ A Melero
May 19, 2011·Proceedings of the National Academy of Sciences of the United States of America·Kurt A SwansonAndrea Carfi
Feb 11, 2012·Proceedings of the National Academy of Sciences of the United States of America·Margarita MagroConcepción Palomo
Mar 3, 2015·American Journal of Respiratory and Critical Care Medicine·Maximillian S HabibiUNKNOWN Mechanisms of Severe Acute Influenza Consortium Investigators
Oct 16, 2015·Science Translational Medicine·Joan O NgwutaBarney S Graham
Aug 2, 2016·Nature Structural & Molecular Biology·M Gordon JoycePeter D Kwong
Nov 3, 2016·Proceedings of the National Academy of Sciences of the United States of America·Jarrod J MousaJames E Crowe
Jun 20, 2018·The Lancet Infectious Diseases·Natalie I MazurUNKNOWN Respiratory Syncytial Virus Network (ReSViNET) Foundation
Mar 1, 2019·Vaccines·Emily PhungTracy J Ruckwardt

❮ Previous
Next ❯

Citations

Sep 25, 2019·The Journal of Infectious Diseases·Octavio RamiloAsuncion Mejias
Oct 8, 2019·Expert Review of Vaccines·Iebe Rossey, Xavier Saelens
Dec 29, 2019·International Immunology·Kosuke Fujimoto, Satoshi Uematsu
Nov 13, 2019·Nature Reviews. Immunology·John R Mascola, Anthony S Fauci
Apr 9, 2020·Expert Opinion on Biological Therapy·Seyhan Boyoglu-Barnum, Ralph A Tripp
May 22, 2020·European Journal of Immunology·Huibin LvChris K P Mok
Jul 15, 2020·The New England Journal of Medicine·Lisa A JacksonUNKNOWN mRNA-1273 Study Group
Jun 28, 2020·The Journal of Infectious Diseases·Ann R Falsey, Edward E Walsh
Aug 9, 2020·Expert Review of Respiratory Medicine·John StambasRalph A Tripp
Aug 19, 2020·Expert Opinion on Pharmacotherapy·Alexis M KalergisSusan M Bueno
Sep 24, 2020·Expert Review of Vaccines·Leonard MoiseAnne S De Groot
Sep 9, 2020·Emerging Microbes & Infections·Tingting LiNingshao Xia
Jul 17, 2020·Frontiers in Immunology·Richard B KennedyGregory A Poland
Aug 7, 2020·Human Vaccines & Immunotherapeutics·Irene Rivero-CalleFederico Martinón-Torres
May 6, 2020·Viral Immunology·Rhiannon R PenkertJulia L Hurwitz
Mar 20, 2020·Science Translational Medicine·Simon B DrysdaleCharles J Sande
Jul 25, 2020·Science·Ching-Lin HsiehJason S McLellan
Jul 23, 2020·Nature·Amber Dance
Jul 30, 2020·The New England Journal of Medicine·Kizzmekia S CorbettBarney S Graham
Jan 29, 2020·Proceedings of the National Academy of Sciences of the United States of America·Mark D LangowskiSheetij Dutta
Oct 10, 2020·PLoS Pathogens·Jiachen HuangJarrod J Mousa
Oct 10, 2020·Science·Maximillian S HabibiPeter J M Openshaw
Jan 13, 2021·Proceedings of the National Academy of Sciences of the United States of America·Rino RappuoliEmmanuel Hanon
Oct 18, 2020·Journal of Biotechnology·Peifeng ChenDaniel B Gowetski
Jan 19, 2021·Advanced Healthcare Materials·William HoXiaoyang Xu
Feb 2, 2021·PLoS Computational Biology·Rustom AntiaJames J Bull
Feb 6, 2021·Nature Reviews. Microbiology·Francesca MicoliDavide Serruto
Aug 7, 2020·Nature·Kizzmekia S CorbettBarney S Graham
Feb 13, 2021·NPJ Vaccines·Joshua T MonradNeil G Cherian
Dec 24, 2020·Nature Reviews. Immunology·Andrew J Pollard, Else M Bijker
Dec 30, 2020·Microorganisms·Sonia BianchiniSusanna Esposito
Jan 6, 2021·Nature Chemical Biology·Che YangBruno E Correia
Nov 15, 2020·Vaccines·Carlotta BiagiMarcello Lanari
Feb 24, 2021·NPJ Vaccines·Nikolaos C KyriakidisEsteban Ortiz Prado

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.